Get notified when LYNX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Standing Risk Factors

  • Material Weakness (unchanged) — The company continues to disclose unremediated material weaknesses in internal control over financial reporting, with no change in status between the two filings.
NYSE: LYNX Lyntris Inc. S-1/A

Lyntris S-1/A: net proceeds to repay $60M debt; dilution per share eases to $21.71

Filed August 12, 2026 · Compared to S-1/A Aug 10, 2026 · ~1 min read

Key Changes

  • high

    The company now specifies it will use approximately $60.0 million of net proceeds from this offering to repay outstanding borrowings under its New Credit Facility.

    MD&A: Use of Proceeds verify on EDGAR →
  • high

    Dilution to new investors decreased from $22.07 to $21.71 per share, reflecting a higher per-share contribution from offering proceeds.

    Dilution verify on EDGAR →
  • medium

    The company disclosed that $15.0 million of cash on hand was used in the July 31, 2026 refinancing, adding specificity to the source of funds.

    MD&A: Refinancing verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.

Partner

Trade LYNX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 30, 2026 · How we verify